title: Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
authors.affiliation: Department of Hematology, University Hospital Rotterdam Dijkzigt, The Netherlands.
authors.forename: P
authors.initials: P
authors.lastname: Sonneveld
authors.forename: W
authors.initials: W
authors.lastname: Hop
authors.forename: A H
authors.initials: AH
authors.lastname: Mulder
authors.forename: J J
authors.initials: JJ
authors.lastname: Michiels
authors.forename: G
authors.initials: G
authors.lastname: Blijham
authors.forename: J
authors.initials: J
authors.lastname: van de Lelie
authors.forename: J W
authors.initials: JW
authors.lastname: Raemakers
authors.forename: K
authors.initials: K
authors.lastname: Nieuwenhuis
authors.forename: C
authors.initials: C
authors.lastname: van der Heul
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D009367:Neoplasm Staging; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D011446:Prospective Studies; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D008942:Mitoxantrone; D011241:Prednisone